Hudson Bay Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.77M | Hold |
155,000
| – | – | 0.01% | 445 |
|
|
2025
Q1 | $3.22M | Hold |
155,000
| – | – | 0.01% | 434 |
|
|
2024
Q4 | $3.65M | Buy |
155,000
+5,000
| +3% | +$118K | 0.01% | 409 |
|
|
2024
Q3 | $3.84M | Buy |
150,000
+80,000
| +114% | +$2.05M | 0.02% | 343 |
|
|
2024
Q2 | $1.64M | Buy |
70,000
+5,000
| +8% | +$117K | 0.01% | 440 |
|
|
2024
Q1 | $1.87M | Hold |
65,000
| – | – | 0.01% | 391 |
|
|
2023
Q4 | $2.13M | Buy |
65,000
+30,000
| +86% | +$984K | 0.01% | 376 |
|
|
2023
Q3 | $975K | Hold |
35,000
| – | – | 0.01% | 483 |
|
|
2023
Q2 | $1.19M | Sell |
35,000
-5,000
| -13% | -$170K | 0.01% | 503 |
|
|
2023
Q1 | $1.2M | Hold |
40,000
| – | – | 0.01% | 530 |
|
|
2022
Q4 | $1.13M | Buy |
40,000
+25,000
| +167% | +$706K | 0.01% | 633 |
|
|
2022
Q3 | $493K | Sell |
15,000
-45,000
| -75% | -$1.48M | ﹤0.01% | 857 |
|
|
2022
Q2 | $1.89M | Buy |
+60,000
| New | +$1.89M | 0.01% | 779 |
|
|
2021
Q3 | – | Sell |
-20,000
| Closed | -$1.85M | – | 957 |
|
|
2021
Q2 | $1.85M | Buy |
+20,000
| New | +$1.85M | 0.02% | 624 |
|